Return to homepagePandemic Pact

Prospective cohort studies on immunosurveillance of SARS-CoV-2 in Switzerland

  • Funded by State Secretariat for Education, Research and Innovation (SERI)
  • Total publications:0 publications

Grant number: 0142005382

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022
    2023

  • Known Financial Commitments (USD)

    $491,809.92

  • Funder

    State Secretariat for Education, Research and Innovation (SERI)

  • Principal Investigator

    Abteilung Übertragbare Krankheiten Sekretariat der

  • Research Location

    N/A

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

With the continuation of the twin study, which is already ongoing, until the end of 2023, important information on the immunological status of the Swiss population will be investigated. These findings provide an additional basis based on evidence-based scientific data, which will be used to develop strategies and recommendations as the pandemic progresses and in particular in view of a possible wave of infections in autumn 2022. The two cohort studies "Zurich Coronavirus Cohort Study" (ZSAC) and "Zurich Coronavirus Vaccination Study" (ZVAC) are population-based, prospective cohort studies that observe representative populations of 1552 recovered (ZSAC) and 575 vaccinated people (ZVAC) respectively since the time of infection with SARS-CoV-2 or vaccination. In March 2022, a follow-up of over 18 months for the ZSAC study and a 10-month follow-up resulted...